# FDA Inspection 1267709 - Eurofins Pharmaceutical Product Testing Belgium NV - March 21, 2025

Source: https://www.keypedia.com/records/fda_inspections/eurofins-pharmaceutical-product-testing-belgium-nv/cf3ced82-c632-4c87-ad46-42135f7c2f03
Source feed: FDA_Inspections

> FDA Inspection 1267709 for Eurofins Pharmaceutical Product Testing Belgium NV on March 21, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1267709
- Company Name: Eurofins Pharmaceutical Product Testing Belgium NV
- Inspection Date: 2025-03-21
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1267709 - 2025-03-21](https://www.keypedia.com/records/fda_inspections/eurofins-pharmaceutical-product-testing-belgium-nv/7843455d-5627-4bfb-a25e-d1f773a3b921)
- [FDA Inspection 1177245 - 2019-08-02](https://www.keypedia.com/records/fda_inspections/eurofins-pharmaceutical-product-testing-belgium-nv/31b874b8-8d60-4dcb-8840-f1b336843973)

Company: https://www.keypedia.com/companies/eurofins-pharmaceutical-product-testing-belgium-nv/b0745143-5941-4354-a58d-1dd38b6b5bfe

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c